	Predicting survival of Hodgkin lymphoma using machine learning-an analysis based on the SEER database. Ann Hematol Cai X, Kang L. PMID: 42056487 [PubMed - indexed for MEDLINE]
	Primary cutaneous T-cell lymphoma (mycosis fungoides and SÃ©zary syndrome): A practical compartment-based review. Blood Rev Mozas P, Combalia A, Antelo G, López-Oreja I, Castrejón de Anta N, Monge-Escartín I, Moreno-Alonso D, Gil-Lianes J, Juncosa M, Salas MQ, Charry P, Albero R, García-Herrera A, López Guillermo A, Estrach T. PMID: 42055866 [PubMed - as supplied by publisher]
	HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials. J Natl Compr Canc Netw Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J. PMID: 42055453 [PubMed - in process]
	CLO26-106: From Vasculitis to NK/T-Cell Lymphoma: A Complex Diagnosis in a Patient With a Midline Tumor and Positive ANCA. J Natl Compr Canc Netw Hernández I, Vargas LP, León JMM, Ballesteros-García MC, Bacca J, Ferro JD, Dorado L, Santoyo-Sarmiento N. PMID: 42055427 [PubMed - in process]
	EPR26-321: Sorafenib Plus Intensive Chemotherapy in Newly Diagnosed Adults With Acute Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials. J Natl Compr Canc Netw Vatvani AD, Nada R, Altamirano MFA, Damara I, Oktrian O, Yausep OE, Shabarek N. PMID: 42055402 [PubMed - in process]
	HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit. J Natl Compr Canc Netw Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J. PMID: 42055401 [PubMed - in process]
	HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia). J Natl Compr Canc Netw Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J. PMID: 42055035 [PubMed - in process]
	Random Survival Forest Versus Elastic-Net Regularized Cox Regression for Survival Prediction in Acute Myeloid Leukemia at Distinct Treatment Time Points: Model Performance Comparison Study. JMIR Bioinform Biotechnol Brady O, Johnson S, Giles P, Alvares C, Zabkiewicz J, Fuentes C. PMID: 42054649 [PubMed]
	Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma. J Clin Oncol Uppal M, Bhinder B, Marderstein AR, Lee Batlevi C, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD, Lue JK, Torka P, Epstein-Peterson ZD, Arcila M, Dogan A, Imber B, Yahalom J, Vardhana SA, Intlekofer A, Raj S, Shouval R, Hodkinson B, Stokes ME, Kittai AS, Brody JD, Elemento O, Salles G, Joffe E. PMID: 42054619 [PubMed - as supplied by publisher]
	TP53 genetic alterations are highly recurrent in Epstein-Barr virus-negative aggressive NK-cell leukemia: insights from an institutional experience and comprehensive literature review. Am J Clin Pathol Gonzalez Mancera M, Wilk AJ, Oak J, Natkunam Y, Silva O. PMID: 42054237 [PubMed - indexed for MEDLINE]
	CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma. Leuk Lymphoma Xiong S, Yue N, Zhang S, Xu Y, Cao J, Liu X, Wu C. PMID: 42054037 [PubMed - as supplied by publisher]
	Navigating Prognostic Dialogue During Serious Illness Conversations. JAMA Netw Open Borregaard Myrhøj C, Jacobsen J, LeBlanc TW, El-Jawahri A, Jarden M, Clemmensen SN, von Heymann A. PMID: 42054029 [PubMed - indexed for MEDLINE]
	Integrating occupational cancer detection into hospital care? An intervention research to improve blood cancer patient care in France (GISCOPE 84). Can J Public Health Hunsmann M, Bertschy S, Amiet É, Aubail A, Bart J, Durand C, Hamdoun F, Rat F, Richier C, Thebaud-Mony A, Zaanane H, Wolf J, Slama B, team of the Hematology-Oncology Department at Avignon Hospital, TheGISCOPE 84 Expert Panel. PMID: 42053922 [PubMed - indexed for MEDLINE]
	Evaluation of DNA methylation-based age prediction accuracy in leukemia patients using a six-CpG model trained on healthy blood. Forensic Sci Med Pathol Can K, Filoglu G, Ersoy G, Ozmen D, Eskazan AE, Ar MC, Bulbul O. PMID: 42053891 [PubMed - as supplied by publisher]
	Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy vs. CD20xCD3 bispecific antibody as third- or later-line treatment in follicular lymphoma: a meta-analysis. Ann Hematol Li X, Liao J, Liu S, Mo X, Wang B. PMID: 42053782 [PubMed - in process]
	EASIX score is predictive of early fatal complications in newly diagnosed acute myeloid leukemia. Ann Hematol Finotto T, Tauveron-Jalenques U, Barrière S, Adelou S, Futier E. PMID: 42053661 [PubMed - in process]
	Age-stratified nomogram development and validation for predicting voriconazole trough concentrations above safety threshold in pediatric patients with hematologic malignancy. Eur J Clin Pharmacol An N, Han Y, Jia C, Ding W, Liu J, Zhao Y. PMID: 42053650 [PubMed - indexed for MEDLINE]
	A PET-radiomics diagnostic signature to differentiate Hodgkin lymphoma from aggressive non-Hodgkin lymphomas. Biomed Tech (Berl) Huang Y, Zhi T, Miao Y, Meng C. PMID: 42053243 [PubMed - as supplied by publisher]
	A Preliminary Study on the Auto-Segmentation of Targets and Organs at Risk in Pediatric Total Marrow and Lymphoid Irradiation. Technol Cancer Res Treat Xie Z, Liu J, Hou L, Feng H, Zhang F, Lu N. PMID: 42053218 [PubMed - indexed for MEDLINE]
	Unraveling the care pathway for CAR T-cell therapy in large B-cell lymphoma: insights from a nationwide study in France (2018-2023). Leuk Lymphoma Thieblemont C, Caillot D, Pierre M, Branchoux S, Lemasson H, Caron A, Nevoret C, Torreton E, Petel A, Despas F. PMID: 42052989 [PubMed - as supplied by publisher]

Articles 1 - 20 / 167359

Page 1 of 8368



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy